TIL is back on HNIs’ radar as co lines up infrastructure
Touted as a fundamental play, TIL shares are back on the radar of some high net worth individuals, who have been accumulating the stock. The scrip, which has gained 18% over the past month, jumped 4% on BSE on Tuesday to close at Rs 348.60.
The company has clocked an earning per share of Rs 12.53 for the half year-ended September. With many infrastructure projects on the anvil for 2010, companies in this segment are expected to gain traction, say analysts. TIL’s principal activities are manufacturing and market heavy engineering equipment used in the infrastructure sector. The firm operates in three segments: construction and mining solutions, power system solutions and material handling solutions.
Bull on a value hunt laps up NHPC despite its poor show
Most investors burnt their fingers subscribing to the initial public offering of state-owned NHPC. After briefly topping its issue price on listing, the stock has been languishing below that mark ever since. Of late, a Rar(e)ing Bull appears to have taken a fancy for the stock.
In the past couple of trading sessions, the Bull is said to have accumulated over 25 lakh shares. It is not clear if he is merely scouting for value, or whether he is anticipating some favourable policy announcement that could benefit the company.
Talk of agro-chem joint venture with MNC lifts Astec Lifesciences
Astec Lifesciences has come on the radar of operators yet again. The buzz in the market is that Astec is planning to enter into a joint venture with a multinational company to expand its agro-chemical product profile. The joint venture, if it materialises, is expected to give a booster shot to the profit and turnover margins of Astec Lifesciences.
According to analysts tracking the company, Astec has been looking for technology support partners to grow its R&D and pharmaceuticals business. “The company could tie up with some research agency or a foreign company to grow its business verticals. A full-fledged JV for product development looks very unlikely at the moment,” said an analyst tracking the company. Shares of Astec Lifesciences ended 0.3% higher at Rs 82.35 on BSE on Tuesday.
(Contributed by Deeptha Rajkumar, Santosh Nair & Shailesh Menon)
******************************************
op 5 picks of the day I Mid-term picks
- Are we in for another bull run?
- Nifty support may come at 5120-5080
- Small companies reward their followers in 2009
Src: ET
